DAXOR CMO John Jefferies Receives 2,451-Share Award

What Happened
John Jefferies, Chief Medical Officer of DAXOR Corp (DXR), was granted/acquired 2,451 shares on August 28, 2026 (transaction code A) at $0.00 per share (total reported value $0). The Form 4 was filed with the SEC on September 1, 2026. This was an award/vesting event (compensation), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-28; Report filed: 2026-09-01 (Form 4).
• Price: $0.00 per share; Total reported value: $0.
• Shares acquired: 2,451 shares.
• Shares owned after transaction: not specified in the filing.
• Footnote: F1 — "2,451 shares granted vest on August 28, 2026."
• Filing timeliness: Form 4 filed on Sept 1 is shown in the record; check official filing for any late-filing flag if timing is a concern.

Context
Awards and immediate vesting are common components of executive compensation and do not carry the same market signal as open-market purchases or sales. Because these shares were granted at no cost, this transaction reflects compensation/vesting rather than a purchase motivated by market outlook. Retail investors should view it as informational rather than a direct bullish or bearish indicator.